HUM vs SER
Humana Inc (HUM) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. SER currently screens at market cap $29.7M.
Not investment advice. Open the HUM and SER stock pages for the full models.
Not investment advice.